Covid-19 pandemic: Abbott to supply over 1 million antibody tests to India
US-based
healthcare technology maker Abbott on Monday said it can supply over one
million of its laboratory-based serology blood test for the detection of the
antibody, IgG (Immunoglobulin G), that identifies if a person has had the novel coronavirus (Covid-19).
Abbott
said it is already in the process of delivering antibody tests to leading
government and private hospitals and labs in Maharashtra, Delhi, West Bengal,
Uttar Pradesh, Jammu and Kashmir and Gujarat.
"Abbott
is pleased to contribute to ICMR's (Indian Council of Medical Research)
Covid-19 antibody testing strategy to use IgG CLIA antibody tests,"
Narendra Varde, General Manager and Country Head at Abbott's diagnostics
business in India, said in a statement. Read More
Comments
Post a Comment